MULTIPLE MYELOMA (MM)

This early-stage study is testing a new cell therapy called LVIVO-TaVec400 for people with multiple myeloma that has returned or stopped responding to standard treatments. The study will enroll about 38 adults who have already tried at least three other therapies. Researchers wil…

This large study is testing a new drug combination (linvoseltamab, bortezomib, lenalidomide) for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. It will compare this new combination, with and without the transplant, against the current st…

This study is testing whether using two newer immunotherapy drugs (teclistamab and talquetamab) at different times during treatment can help people with high-risk multiple myeloma live longer without their cancer progressing. It will enroll 50 adults with newly diagnosed, aggress…

This study aims to test a new, under-the-skin injection called HLX15-SC for people newly diagnosed with multiple myeloma who are not eligible for a stem cell transplant. Researchers will compare it to an existing approved treatment (DARZALEX FASPRO®) to see if it works similarly …

This is an early-stage study to test the safety and initial effectiveness of a new cell therapy called QI-019A in adults with multiple myeloma that has come back or stopped responding to standard treatments. The therapy involves modifying a patient's own immune cells to target th…

This early-stage study aims to test the safety and early effectiveness of an investigational drug called BT02 for adults with blood cancers that have returned or not responded to previous treatments. Participants will receive BT02 through an IV every few weeks for up to two years…

This study aims to see if a new drug called CM336 works better than current standard treatments for people with multiple myeloma that has returned or stopped responding to previous therapies. It will involve about 280 adults whose cancer has progressed after at least two prior tr…

This study is testing a new type of imaging scan for people with multiple myeloma, a blood cancer. The scan uses a special tracer that attaches to a protein found on myeloma cells. Researchers want to see if this new scan can find cancer spots more accurately than the current sta…

This study aims to see if a 12-week physical exercise program can improve the quality of life, reduce frailty, and help with mental health for people being treated for multiple myeloma, a type of blood cancer. Researchers will compare a supervised exercise group with a home-based…

This study is testing whether a 16-week lifestyle program focused on diet and exercise can help improve physical function and quality of life for people living with multiple myeloma. Researchers will enroll 184 adults who have been diagnosed for at least one year and are medicall…

This study is testing whether adding a special breathing exercise routine to standard physical therapy can improve heart and lung health in people with multiple myeloma, a type of blood cancer. Twenty-six patients currently receiving treatment will be split into two groups: one d…